Research Article

CNDP1, NOS3, and MnSOD Polymorphisms as Risk Factors for Diabetic Nephropathy among Type 2 Diabetic Patients in Malaysia

Table 1

Inclusion and exclusion criteria.

No.Inclusion criteria of nephropathy groupInclusion criteria of without nephropathy groupExclusion criteria

1Biologically unrelatedBiologically unrelatedBiologically related
2Age onset ≥ 35 yearsAge onset ≥ 35 yearsAge onset ≤ 35 years
3Diabetes duration ≥ 10 yearsDiabetes duration ≥ 10 yearsDiabetes duration ≤ 10 years
4Fasting plasma glucose ≥ 7.0 mmol/LFasting plasma glucose ≥ 7.0 mmol/LNormal fasting glucose level
5Albumin excretion rate > 300 mg/24 hAlbumin excretion rate < 30 mg/24 hNondiabetic and normal rate
6Albumin creatinine ratio is >3.5 mg/mmol for women and >2.5 mg/mmol for menAlbumin creatinine ratio is <3.5 mg/mmol for women and <2.5 mg/mmol for menPatients without renal symptoms with a duration of <10 years of diabetes
7ESRD of T2D patientsNon-ESRD of T2DM patientsUnclear of renal damage and ESRD or non-ESRD of T1DM patients
8Glycated hemoglobin (HbA1c) > 6.6%Glycated hemoglobin (HbA1c) ≤ 6.5%Glycated hemoglobin (HbA1c) < 6.5%

ESRD = end-stage renal disease; T2DM = type 2 diabetes mellitus; T1DM = type 1 diabetes mellitus.